Adding to Multiplex Molecular Dx Capabilities, Qiagen Inks Deal to Acquire eGene for $34M | GenomeWeb
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
Following through on earlier statements that it planned to be aggressive in the mergers and acquisitions market this year, Qiagen last week signed a deal to acquire sample-separation technology company eGene in a cash and stock deal valued at around $34 million.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.